Tango Therapeutics, Inc.
TNGX
Cena:
$ 20.24
-1.38 (-6.38%)
Valuace
70
Růst
0
Zdraví
75
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
TANGO THERAPEUTICS ANNOUNCES CEO TRANSITION: BARBARA WEBER TO RETIRE, MALTE PETERS APPOINTED SUCCESSOR
08-01-2026
BOSTON, JAN. 08, 2026 (GLOBE NEWSWIRE) -- TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), A CLINICAL-STAGE ...
Více zde
TANGO THERAPEUTICS APPOINTS SUNG LEE TO BOARD OF DIRECTORS
05-01-2026
BOSTON, JAN. 05, 2026 (GLOBE NEWSWIRE) -- TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), A CLINICAL-STAGE ...
Více zde
TANGO THERAPEUTICS TO PARTICIPATE IN 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
17-12-2025
BOSTON, DEC. 17, 2025 (GLOBE NEWSWIRE) -- TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), TODAY ANNOUNCED T...
Více zde
TANGO THERAPEUTICS TO PARTICIPATE IN THE PIPER SANDLER 37TH ANNUAL HEALTHCARE CONFERENCE
26-11-2025
BOSTON, NOV. 26, 2025 (GLOBE NEWSWIRE) -- TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), TODAY ANNOUNCED T...
Více zde
TANGO THERAPEUTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS HIGHLIGHTS
04-11-2025
- DATA UPDATE FROM VOPIMETOSTAT (TNG462) SHOWED 2L MTAP-DEL PANCREATIC CANCER MEDIAN PROGRESSION FRE...
Více zde
TANGO THERAPEUTICS, INC. (TNGX) DISCUSSES POSITIVE CLINICAL DATA AND DEVELOPMENT PLANS FOR VOPIMETOSTAT IN MTAP-DELETED CANCERS TRANSCRIPT
23-10-2025
TANGO THERAPEUTICS, INC. (NASDAQ:TNGX ) DISCUSSES POSITIVE CLINICAL DATA AND DEVELOPMENT PLANS FOR V...
Více zde
TANGO THERAPEUTICS ANNOUNCES $225 MILLION FINANCING
23-10-2025
FINANCING PARTICIPANTS INCLUDE FARALLON CAPITAL MANAGEMENT, TCGX, BALYASNY ASSET MANAGEMENT, WOODLIN...
Více zde
TANGO THERAPEUTICS REPORTS POSITIVE DATA FROM ONGOING PHASE 1/2 STUDY WITH VOPIMETOSTAT (TNG462) IN PATIENTS WITH MTAP-DELETED CANCERS
23-10-2025
- 2L MTAP-DEL PANCREATIC CANCER MEDIAN PROGRESSION FREE SURVIVAL (MPFS) 7. 2 MONTHS WITH AN OBJECTIV...
Více zde
TANGO THERAPEUTICS TO PRESENT FIRST CLINICAL DATA FROM TNG260 AT SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) ANNUAL MEETING 2025
06-10-2025
BOSTON, OCT. 06, 2025 (GLOBE NEWSWIRE) -- TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), A CLINICAL-STAGE ...
Více zde
TANGO THERAPEUTICS TO PARTICIPATE IN THE 2025 CANTOR GLOBAL HEALTHCARE CONFERENCE
26-08-2025
BOSTON, AUG. 26, 2025 (GLOBE NEWSWIRE) -- TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), TODAY ANNOUNCED T...
Více zde
TANGO THERAPEUTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS HIGHLIGHTS
05-08-2025
– FIRST PATIENT DOSED IN COMBINATION TRIAL OF TNG462 AND REVOLUTION MEDICINES RAS(ON) INHIBITORS ...
Více zde
TANGO THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 1/2 TRIAL OF TNG462 PLUS REVOLUTION MEDICINES' DARAXONRASIB OR ZOLDONRASIB IN PATIENTS WITH RAS-MUTANT MTAP-DELETED PANCREATIC OR LUNG CANCER
27-06-2025
BOSTON, JUNE 27, 2025 (GLOBE NEWSWIRE) -- TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), A CLINICAL-STAGE ...
Více zde
TANGO THERAPEUTICS TO PARTICIPATE IN THE 46TH ANNUAL GOLDMAN SACHS GLOBAL HEALTHCARE CONFERENCE
27-05-2025
BOSTON, MAY 27, 2025 (GLOBE NEWSWIRE) -- TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), TODAY ANNOUNCED T...
Více zde
TANGO THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN TNG456 PHASE 1/2 TRIAL IN PATIENTS WITH MTAP-DELETED GLIOBLASTOMAS AND OTHER SOLID TUMORS
21-05-2025
BOSTON, MAY 21, 2025 (GLOBE NEWSWIRE) -- TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), A CLINICAL-STAGE B...
Více zde
TANGO THERAPEUTICS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS HIGHLIGHTS
12-05-2025
– DATA UPDATE FROM ONGOING TNG462 PHASE 1/2 MONOTHERAPY TRIAL EXPECTED 2H 2025 – – COMBINATIO...
Více zde
TANGO THERAPEUTICS TO REPORT FIRST QUARTER 2025 FINANCIAL RESULTS ON MONDAY, MAY 12, 2025
01-05-2025
BOSTON, MAY 01, 2025 (GLOBE NEWSWIRE) -- TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), TODAY ANNOUNCED TH...
Více zde
TANGO THERAPEUTICS TO HIGHLIGHT PRECLINICAL DATA ON PRECISION ONCOLOGY PIPELINE WITH FIVE POSTERS AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) ANNUAL MEETING 2025
25-03-2025
BOSTON, MARCH 25, 2025 (GLOBE NEWSWIRE) -- TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), A CLINICAL-STAGE...
Více zde
TANGO THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS HIGHLIGHTS
27-02-2025
– TNG462 GRANTED ORPHAN DRUG DESIGNATION FOR TREATMENT OF PANCREATIC CANCER – – INVESTIGATION...
Více zde
TANGO THERAPEUTICS TO PRESENT AT THE GUGGENHEIM SMID CAP BIOTECHNOLOGY CONFERENCE
30-01-2025
BOSTON, JAN. 30, 2025 (GLOBE NEWSWIRE) -- TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), A CLINICAL-STAGE...
Více zde
TANGO THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
03-12-2024
BOSTON--(BUSINESS WIRE)--TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), A CLINICAL-STAGE BIOTECHNOLOGY COM...
Více zde
TANGO THERAPEUTICS TO PRESENT AT THE PIPER SANDLER 36TH ANNUAL HEALTHCARE CONFERENCE
27-11-2024
BOSTON--(BUSINESS WIRE)--TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), A CLINICAL-STAGE BIOTECHNOLOGY COM...
Více zde
TANGO THERAPEUTICS TO PRESENT AT THE GOLDMAN SACHS 45TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
05-06-2024
BOSTON--(BUSINESS WIRE)--TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), A CLINICAL-STAGE BIOTECHNOLOGY COM...
Více zde
MEDIVIR´S LICENSEE, TANGO THERAPEUTICS, HAS DISCONTINUED DEVELOPMENT OF ITS TNG348 CLINICAL PROGRAM
23-05-2024
STOCKHOLM , MAY 23, 2024 /PRNEWSWIRE/ -- MEDIVIR AB (NASDAQ STOCKHOLM: MVIR), A PHARMACEUTICAL COMPA...
Více zde
TANGO THERAPEUTICS ANNOUNCES DISCONTINUATION OF TNG348 PROGRAM
23-05-2024
BOSTON--(BUSINESS WIRE)--TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), A CLINICAL-STAGE BIOTECHNOLOGY COM...
Více zde
TANGO THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
01-04-2024
BOSTON--(BUSINESS WIRE)--TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), A CLINICAL-STAGE BIOTECHNOLOGY COM...
Více zde
TANGO THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS HIGHLIGHTS
18-03-2024
BOSTON--(BUSINESS WIRE)--TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), A CLINICAL-STAGE BIOTECHNOLOGY COM...
Více zde
TANGO THERAPEUTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
06-03-2024
BOSTON--(BUSINESS WIRE)--TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), A CLINICAL-STAGE BIOTECHNOLOGY COM...
Více zde
TANGO THERAPEUTICS TO HIGHLIGHT PRECLINICAL DATA ON PRECISION ONCOLOGY PIPELINE AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) ANNUAL MEETING 2024
05-03-2024
BOSTON, MARCH 05, 2024 (GLOBE NEWSWIRE) -- TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), A CLINICAL-STAGE...
Více zde
TANGO THERAPEUTICS TO PRESENT AT THE GUGGENHEIM HEALTHCARE TALKS | 6TH ANNUAL BIOTECHNOLOGY CONFERENCE
31-01-2024
BOSTON, JAN. 31, 2024 (GLOBE NEWSWIRE) -- TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), A CLINICAL-STAGE ...
Více zde
TANGO THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
05-01-2024
BOSTON, MASS., JAN. 05, 2024 (GLOBE NEWSWIRE) -- TANGO THERAPEUTICS, INC. (NASDAQ: TNGX), A CLINICAL...
Více zde
| Datum | Typ | Otevřít EDGAR | Stáhnout dokument |
|---|---|---|---|
| 2026-01-08 00:00:00 | 8-K | Stáhnout | |
| 2026-01-05 00:00:00 | 8-K | Stáhnout | |
| 2025-11-21 00:00:00 | 8-K | Stáhnout | |
| 2025-11-04 00:00:00 | 8-K | Stáhnout | |
| 2025-11-04 00:00:00 | 10-Q | Stáhnout | |
| 2025-10-24 01:00:00 | 8-K | Stáhnout | |
| 2025-10-24 00:00:00 | 8-K | Stáhnout | |
| 2025-10-23 01:00:00 | 8-K | Stáhnout | |
| 2025-10-23 00:00:00 | 8-K | Stáhnout | |
| 2025-08-25 01:00:00 | 8-K | Stáhnout | |
| 2025-08-25 00:00:00 | 8-K | Stáhnout | |
| 2025-08-05 01:00:00 | 8-K | Stáhnout | |
| 2025-08-05 01:00:00 | 10-Q | Stáhnout | |
| 2025-08-05 00:00:00 | 8-K | Stáhnout | |
| 2025-08-05 00:00:00 | 10-Q | Stáhnout | |
| 2025-06-06 01:00:00 | 8-K | Stáhnout | |
| 2025-06-06 00:00:00 | 8-K | Stáhnout | |
| 2025-05-12 01:00:00 | 8-K | Stáhnout | |
| 2025-05-12 01:00:00 | 10-Q | Stáhnout | |
| 2025-05-12 00:00:00 | 8-K | Stáhnout | |
| 2025-05-12 00:00:00 | 10-Q | Stáhnout | |
| 2025-02-27 00:00:00 | 8-K | Stáhnout | |
| 2025-02-27 00:00:00 | 10-K | Stáhnout | |
| 2025-02-26 23:00:00 | 8-K | Stáhnout | |
| 2025-02-26 23:00:00 | 10-K | Stáhnout | |
| 2025-01-13 00:00:00 | 8-K | Stáhnout | |
| 2025-01-12 23:00:00 | 8-K | Stáhnout | |
| 2024-11-06 00:00:00 | 8-K | Stáhnout | |
| 2024-11-06 00:00:00 | 10-Q | Stáhnout | |
| 2024-11-05 23:00:00 | 8-K | Stáhnout | |
| 2024-11-05 23:00:00 | 10-Q | Stáhnout | |
| 2024-08-07 01:00:00 | 8-K | Stáhnout | |
| 2024-08-07 01:00:00 | 10-Q | Stáhnout | |
| 2024-08-07 00:00:00 | 8-K | Stáhnout | |
| 2024-08-07 00:00:00 | 10-Q | Stáhnout | |
| 2024-06-06 01:00:00 | 8-K | Stáhnout | |
| 2024-06-06 00:00:00 | 8-K | Stáhnout | |
| 2024-05-23 01:00:00 | 8-K | Stáhnout | |
| 2024-05-23 00:00:00 | 8-K | Stáhnout | |
| 2024-05-08 01:00:00 | 8-K | Stáhnout | |
| 2024-05-08 01:00:00 | 10-Q | Stáhnout | |
| 2024-05-08 00:00:00 | 8-K | Stáhnout | |
| 2024-05-08 00:00:00 | 10-Q | Stáhnout | |
| 2024-03-18 00:00:00 | 8-K | Stáhnout | |
| 2024-03-18 00:00:00 | 10-K | Stáhnout | |
| 2024-03-17 23:00:00 | 8-K | Stáhnout | |
| 2024-03-17 23:00:00 | 10-K | Stáhnout | |
| 2024-02-07 00:00:00 | 8-K | Stáhnout | |
| 2024-02-06 23:00:00 | 8-K | Stáhnout | |
| 2023-11-08 00:00:00 | 8-K | Stáhnout | |
| 2023-11-08 00:00:00 | 10-Q | Stáhnout | |
| 2023-11-07 23:00:00 | 8-K | Stáhnout | |
| 2023-11-07 23:00:00 | 10-Q | Stáhnout | |
| 2023-08-30 01:00:00 | 8-K | Stáhnout | |
| 2023-08-30 00:00:00 | 8-K | Stáhnout | |
| 2023-08-10 01:00:00 | 8-K | Stáhnout | |
| 2023-08-10 00:00:00 | 8-K | Stáhnout | |
| 2023-08-07 01:00:00 | 8-K | Stáhnout | |
| 2023-08-07 01:00:00 | 10-Q | Stáhnout | |
| 2023-08-07 00:00:00 | 8-K | Stáhnout | |
| 2023-08-07 00:00:00 | 10-Q | Stáhnout | |
| 2023-06-07 01:00:00 | 8-K | Stáhnout | |
| 2023-06-07 00:00:00 | 8-K | Stáhnout | |
| 2023-05-09 01:00:00 | 8-K | Stáhnout | |
| 2023-05-09 01:00:00 | 10-Q | Stáhnout | |
| 2023-05-09 00:00:00 | 8-K | Stáhnout | |
| 2023-05-09 00:00:00 | 10-Q | Stáhnout | |
| 2023-03-27 01:00:00 | 8-K | Stáhnout | |
| 2023-03-27 01:00:00 | 10-K | Stáhnout | |
| 2023-03-27 00:00:00 | 8-K | Stáhnout | |
| 2023-03-27 00:00:00 | 10-K | Stáhnout | |
| 2023-02-28 00:00:00 | 8-K | Stáhnout | |
| 2023-02-27 23:00:00 | 8-K | Stáhnout | |
| 2022-11-10 00:00:00 | 8-K | Stáhnout | |
| 2022-11-10 00:00:00 | 10-Q | Stáhnout | |
| 2022-11-09 23:00:00 | 8-K | Stáhnout | |
| 2022-11-09 23:00:00 | 10-Q | Stáhnout | |
| 2022-08-10 01:00:00 | 8-K | Stáhnout | |
| 2022-08-10 01:00:00 | 10-Q | Stáhnout | |
| 2022-08-10 00:00:00 | 8-K | Stáhnout | |
| 2022-08-10 00:00:00 | 10-Q | Stáhnout | |
| 2022-06-10 01:00:00 | 8-K | Stáhnout | |
| 2022-06-10 00:00:00 | 8-K | Stáhnout | |
| 2022-05-11 01:00:00 | 8-K | Stáhnout | |
| 2022-05-11 01:00:00 | 10-Q | Stáhnout | |
| 2022-05-11 00:00:00 | 8-K | Stáhnout | |
| 2022-05-11 00:00:00 | 10-Q | Stáhnout | |
| 2022-03-28 01:00:00 | 8-K | Stáhnout | |
| 2022-03-28 01:00:00 | 10-K | Stáhnout | |
| 2022-03-28 00:00:00 | 8-K | Stáhnout | |
| 2022-03-28 00:00:00 | 10-K | Stáhnout | |
| 2021-11-09 00:00:00 | 8-K | Stáhnout | |
| 2021-11-09 00:00:00 | 10-Q | Stáhnout | |
| 2021-11-08 23:00:00 | 8-K | Stáhnout | |
| 2021-11-08 23:00:00 | 10-Q | Stáhnout | |
| 2021-08-13 01:00:00 | 8-K | Stáhnout | |
| 2021-08-13 00:00:00 | 8-K | Stáhnout | |
| 2021-08-09 01:00:00 | 10-Q | Stáhnout | |
| 2021-08-09 00:00:00 | 10-Q | Stáhnout | |
| 2021-05-14 01:00:00 | 10-Q | Stáhnout | |
| 2021-05-14 00:00:00 | 10-Q | Stáhnout | |
| 2021-04-14 01:00:00 | 8-K | Stáhnout | |
| 2021-04-14 00:00:00 | 8-K | Stáhnout | |
| 2021-03-31 01:00:00 | 10-K | Stáhnout | |
| 2021-03-31 00:00:00 | 10-K | Stáhnout | |
| 2020-11-13 00:00:00 | 10-Q | Stáhnout | |
| 2020-11-12 23:00:00 | 10-Q | Stáhnout | |
| 2020-10-07 01:00:00 | 8-K | Stáhnout | |
| 2020-10-07 00:00:00 | 8-K | Stáhnout | |
| 2020-09-14 01:00:00 | 8-K | Stáhnout | |
| 2020-09-14 00:00:00 | 8-K | Stáhnout | |
| 2020-09-09 01:00:00 | 8-K | Stáhnout | |
| 2020-09-09 00:00:00 | 8-K | Stáhnout |
